---
title: "ORIORDAN ANNE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/062fdc9f-c837-5c58-bb53-b28f56e0a809
json: https://whiteintel.dev/api/public/dossier/062fdc9f-c837-5c58-bb53-b28f56e0a809
identifier: sec:0001767870
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ORIORDAN ANNE

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001767870`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/062fdc9f-c837-5c58-bb53-b28f56e0a809  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/062fdc9f-c837-5c58-bb53-b28f56e0a809  

## Ownership & control

### Holdings / subsidiaries

- **Jazz Pharmaceuticals plc** (director) — https://whiteintel.dev/entity/93c43bdd-29a5-5302-94c3-e122c135c53f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ORIORDAN ANNE**. Human view: https://whiteintel.dev/entity/062fdc9f-c837-5c58-bb53-b28f56e0a809 · Structured JSON: https://whiteintel.dev/api/public/dossier/062fdc9f-c837-5c58-bb53-b28f56e0a809._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._